These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28192622)

  • 21. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
    Rombouts SA; Baillie A; Haber PS; Morley KC
    Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: a meta-analysis of randomized controlled trials.
    Lesouef N; Bellet F; Mounier G; Beyens MN
    Therapie; 2014; 69(5):427-35. PubMed ID: 25230278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
    Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baclofen for the treatment of alcohol dependence.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):11-4. PubMed ID: 22998536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.
    Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L
    Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
    Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
    Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
    Falk DE; Ryan ML; Fertig JB; Devine EG; Cruz R; Brown ES; Burns H; Salloum IM; Newport DJ; Mendelson J; Galloway G; Kampman K; Brooks C; Green AI; Brunette MF; Rosenthal RN; Dunn KE; Strain EC; Ray L; Shoptaw S; Ait-Daoud Tiouririne N; Gunderson EW; Ransom J; Scott C; Leggio L; Caras S; Mason BJ; Litten RZ;
    Alcohol Clin Exp Res; 2019 Jan; 43(1):158-169. PubMed ID: 30403402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with baclofen in the management of alcohol-dependent patients with psychiatric comorbidity: a selected case series.
    Dore GM; Lo K; Juckes L; Bezyan S; Latt N
    Alcohol Alcohol; 2011; 46(6):714-20. PubMed ID: 21890485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study.
    Corwin RL; Boan J; Peters KF; Ulbrecht JS
    Behav Pharmacol; 2012 Sep; 23(5-6):616-25. PubMed ID: 22854310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baclofen for alcohol dependence: a preliminary open-label study.
    Flannery BA; Garbutt JC; Cody MW; Renn W; Grace K; Osborne M; Crosby K; Morreale M; Trivette A
    Alcohol Clin Exp Res; 2004 Oct; 28(10):1517-23. PubMed ID: 15597084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis.
    Agabio R; Baldwin DS; Amaro H; Leggio L; Sinclair JMA
    Neurosci Biobehav Rev; 2021 Jun; 125():296-313. PubMed ID: 33454289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.
    Ryan ML; Falk DE; Fertig JB; Rendenbach-Mueller B; Katz DA; Tracy KA; Strain EC; Dunn KE; Kampman K; Mahoney E; Ciraulo DA; Sickles-Colaneri L; Ait-Daoud N; Johnson BA; Ransom J; Scott C; Koob GF; Litten RZ
    Neuropsychopharmacology; 2017 Apr; 42(5):1012-1023. PubMed ID: 27658483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.